Medical Services Expenditures by Disease: Diseases of the Genitourinary System, MEPS Account Basis (DIGESYEXPMEPS) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Medical Services Expenditures by Disease: Diseases of the Genitourinary System, MEPS Account Basis (DIGESYEXPMEPS) from 2000 to 2021 about genitourinary, disease, healthcare, medical, health, expenditures, services, and USA.
AI analysis
Dataset Analysis: Medical Services Expenditures — Genitourinary Diseases (MEPS)
1. Dataset Overview and Value
This dataset (FRED series DIGESYEXPMEPS) tracks annual U.S. medical expenditures for treating diseases of the genitourinary system, sourced from the Medical Expenditure Panel Survey (MEPS) account basis. The data is published via the St. Louis Fed's FRED API (https://fred.stlouisfed.org/graph/fredgraph.csv?id=DIGESYEXPMEPS), a highly reputable and stable government-affiliated aggregator, meaning the underlying MEPS methodology is consistent and well-documented — a strong foundation for longitudinal analysis. Covering 2000–2021 (22 annual observations), this is a low-frequency but long-horizon time series well-suited for macro-level healthcare cost trend analysis, particularly in studies of disease-specific spending relative to GDP, insurance coverage rates, or demographic shifts (e.g., aging population driving genitourinary conditions like kidney disease or prostate issues).
2. Data Quality Observations
Data quality here is excellent at face value: zero null cells across both columns, and each column shows 22 distinct values matching the 22 total rows — indicating no duplicate observation dates and a complete, gap-free annual series. There are no disproportionate nulls to flag. However, some caveats remain unresolved: the duplicate-row count is marked "pending Phase D recomputation," and sample rows are not yet available for visual inspection, so we cannot fully verify formatting consistency (e.g., units, decimal precision) or confirm the absence of hidden duplicate timestamps beyond what distinct-count analysis suggests. Given FRED's standard practices, this series is likely already vetted/cleaned upstream, but final validation should await the Parquet-based Phase D re-check.
3. Key Column Distributions
The value column (DIGESYEXPMEPS, in billions of dollars) ranges from $39.99B to $113.86B, nearly a 3x spread over the period — reflecting substantial real growth in genitourinary-related healthcare spending. The mean ($79.97B) sits slightly above the median ($77.60B), with a near-zero skew (-0.0697), indicating a roughly symmetric distribution with no significant outlier years distorting the trend. The interquartile range ($70.79B–$94.24B) captures the middle 50% of observations tightly, while the standard deviation of $20.52B (about 26% of the mean) signals meaningful year-over-year variability consistent with a steadily rising trend rather than volatile noise — typical of healthcare cost time series that grow with inflation, utilization, and demographic change.
4. Recommended Join Keys
The clear join key is observationdate (annual, January 1st of each year, 2000–2021). Since this is a low-frequency annual series, it pairs best with other annual datasets; if joining to quarterly or monthly series (e.g., CPI medical care index, employment data), aggregate those to annual averages or resample this series appropriately before merging. Given the U.S.-only national scope, no geographic join key exists — cross-dataset joins should also be restricted to U.S.-level series unless disaggregating by state-level MEPS extracts (not present here).
5. Suggested Complementary Datasets
Strong correlation candidates include: (a) other MEPS disease-expenditure series (e.g., circulatory, endocrine/diabetes, musculoskeletal diseases) to compare relative growth rates and spending share shifts; (b) CPI for Medical Care / Medical Care Services (BLS) to distinguish price inflation from utilization growth; (c) health insurance coverage rates (Census/CPS ASEC) to test whether expanded coverage (e.g., post-ACA 2010+) correlates with expenditure jumps; (d) demographic data such as population aged 65+ (Census/BLS) given genitourinary disease prevalence increases with age; and (e) National Health Expenditure (NHE) aggregate data from CMS to contextualize this disease category's share of total U.S. healthcare spending over time.
Columns
- observation_date (date)
- DIGESYEXPMEPS (decimal)